|
Market Closed -
Australian S.E.
09:10:18 02/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.360 AUD | +1.46% |
|
-21.13% | -32.91% |
| 08-28 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold from Speculative Buy; Price Target is AU$10 | MT |
| 08-27 | Clinuvel Pharmaceuticals Limited, 2026 Earnings Call, Aug 27, 2026 |
Chart: Technical Analysis
Stock exchange
Australian S.E.
CUV 8.360 $
+1.46%
1.57M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Australian S.E.
| CUV | 8.360AUD | +1.46% | 1.57M $ | |
Tradegate
| UR9 | 5.280EUR | -0.11% | 37.26K € | |
|
Boerse Muenchen
| UR9 | 5.304EUR | +0.99% | 5.12K € | |
|
Börse Stuttgart
| UR9 | 5.222EUR | -0.08% | 1.07K € | |
|
OTC Markets
| CLVLF | 5.920USD | -1.00% | 592 $ | |
|
Berne S.E.
| UR9 | 5.745CHF | +1.39% | 574.5 CHF | |
|
Deutsche Boerse AG
| UR9 | 5.300EUR | +4.95% | 455.8 € | |
Nasdaq
| CUVL | 6.200USD | -0.64% | 213K $ | |
|
CBOE
| CUVL | 6.225USD | -1.19% | 2.8K $ | |
|
Boerse Muenchen
| UR9A | 5.600EUR | +6.67% | 610.4 € | |
|
Deutsche Boerse AG
| UR9A | 4.920EUR | +2.07% | 0 € | |
|
Börse Stuttgart
| UR9A | 5.150EUR | +0.98% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 9.5 | 9.5 | 10.42 |
| Spread/Res. | -12.00% | -12.00% | -19.77% |
| Spread/Supp. | +4.24% | +4.24% | +7.87% |
| Support | 8.02 | 8.02 | 7.75 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
